Erasmus University Medical Center, Rotterdam, The Netherlands.
On October 11, 2011, the U.S. Preventive Services Task Force (USPSTF) issued a draft report on prostate specific antigen (PSA)-based screening for prostate cancer, giving it a grade D recommendation. Grade D means that "the USPSTF recommends against the service" because it has concluded that "there is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits." This recommendation contradicts the view that PSA-based screening saves lives by reducing the risk of death from prostate cancer. The task force acknowledges that "clinical decisions involve more considerations than evidence alone" and that "clinicians . . .
Written by:
Schröder FH. Are you the author?
Reference: N Engl J Med. 2011 Oct 26. Epub ahead of print.
doi: 10.1056/NEJMp1112140
PubMed Abstract
PMID: 22029756
UroToday.com Prostate Cancer Section
